PUM2 and colonic neoplasm: To explore the possibility of using PUM1 and PUM2 as targets for anti-cancer treatment, we further investigated the in vivo antitumor activity of siRNA-loaded nanoparticles using the orthotopic colon cancer models (Fig. 6a)57.